Drugs / Recombinant tissue plasminogen activator
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00781378 | Jun 2002 → Feb 2006 | pulmonary embolism, venous thromboembolism | Beijing Chao Yang Hospital | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Recombinant tissue plasminogen activator | “Recombinant tissue plasminogen activator” NCT00781378 ↗ |
| Known as | rt-PA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00781378 ↗ |
| Modality | Protein / enzyme biologic | “Recombinant tissue-type plasminogen activator (rt-PA)” NCT00781378 ↗ |
| Route | Intravenous | “rt-PA 100 mg continuous intravenous infusion for 2 hours” NCT00781378 ↗ |